Comment
The therapeutic effect of Mysteclin syrup clearly exceeded the consistent, small improvement seen with placebo. Topical steroid preparations are the other main form of treatment for aphthous ulcers, but these need to be started at the prodromal stage, before frank ulceration develops, and dosage must be carefully restricted to avoid systemic effects. Our findings show that Mysteclin is efficacious irrespective of the phase of the disorder and suggest that the improvement is maintained for at least four weeks after treatment is stopped. Further work will determine whether complete remission can be produced by prolonging treatment enough to eliminate the bacteria responsible for putative antigenic cross-reactions. concentrations of the Maasai were taken into account by considering the ratio of HDL to total cholesterol, there was no significant difference between the Maasai and Europeans. The values reported here are much lower than those found in Nigerian men4 and rural black South Africans,5 whose mean HDL:TC ratios are about twice that found in the Maasai. Further work on populations with differing incidences of heart disease is thus required, but at present it seems that the relation between coronary heart disease and indices such as HDL or the HDL:TC ratio is far from straightforward.
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Unprocessed bran causing intestinal obstruction
Unprocessed bran has been widely advocated by the medical profession and the lay press for the management of constipation, the irritable colon syndrome, and diverticular disease. We report a patient who developed intestinal obstruction due to excessive intake of bran.
Case report
A 53-year-old housewife was admitted to hospital complaining of nausea, cramping abdominal pains, distension, and incontinence of faeces for three days. She had a 20-year history of chronic anxiety requiring treatment with imipramine in doses of up to 150 mg/day. Over this period she had had chronic constipation for which she took two Coloxyl with Danthron tablets (dioctyl sodium sulphosuccinate 50 mg with 1,8-dihydroxy anthraquinone 50 mg) nightly.
A year before admission she began taking about 20 g/day of unprocessed bran. Subsequent improvement in her bowel actions encouraged her to increase her intake progressively, culminating in consumption of 160-200 g/
